Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
14.9
% (year-on-year change in revenue)Wording
Conditional
How definitive the wording is.Results for this period
First quarter2025年6月1日〜2025年8月31日ConsolidatedJapanese GAAPNet Sales1,561¥ millionYear on year +14.9%Progress 24.4%
Operating profit24¥ millionProgress 8.9%
Ordinary income53¥ millionProgress 22.7%
Net income attributable to owners of the parent21¥ millionProgress 17.4%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥2.40
Financial position at period-end
Total assets4,246¥ million
of which net assets 1,932 ¥ millionEquity ratio 44.0%vs. prior year-end +1.9pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueMedia and Platform Business ¥254,820 thousand (YoY -11.6%), Healthcare Institution Management Support Business ¥1,152,243 thousand (YoY +21.6%), Medical B2B Business ¥33,184 thousand (YoY -9.1%), Cloud Integration Business ¥123,208 thousand (YoY +58.4%), Other regions ¥45 thousand (YoY -94.8%)
Segment profitMedia and Platform Business ¥126,281 thousand (YoY -20.2%), Healthcare Institution Management Support Business ¥12,538 thousand (YoY -31.1%), Medical B2B Business ¥-650 thousand, Cloud Integration Business ¥25,508 thousand (YoY +581.2%), Other regions ¥45 thousand (YoY -94.8%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥6,400 million (YoY +5.3%)
Operating profit¥270 million (YoY +173.3%)
Ordinary income¥233 million (YoY +72.4%)
Net income¥121 million
Annual Dividend Forecast¥3.00 → ¥3.00（0.0）
Factors Behind Changes in Business Performance
既存事業のさらなる効率化、歯科業界でのプラットフォーム構築や新サービス開発に取り組み、事業を拡大したこと。HP制作・メンテナンス、歯科医院運営、歯科商社、クラウドインテグレーションでは受注やサービス販売が増加した。
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 1社（株式会社ミルテル）
Impairment lossNone recognized in the current first quarter
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on Disposal of Fixed Assets ¥1,434 thousand
Depreciation and amortization¥7,489 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo
Issued Shares at Period-End10,773,000 shares
Treasury Shares at Period-End1,502,530株
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年6月1日〜2025年8月31日 |
| Net Sales | ¥1,561 million (YoY +14.9%) |
| Operating profit | ¥24 million |
| Ordinary income | ¥53 million |
| Profit attributable to owners of the parent | ¥21 million |
| Net income per share | ¥2.40 |
| Equity ratio | End of the current fiscal period 44 / End of previous period 42.1 |
| Total assets | ¥4,246 million |
| Net assets | ¥1,932 million |
| Full-year earnings forecast | Net Sales ¥6,400 million (YoY +5.3%) / Operating profit ¥270 million (YoY +173.3%) / Ordinary income ¥233 million (YoY +72.4%) / Net income ¥121 million |
| Annual Dividend Forecast | ¥3.00 → ¥3.00（0.0） |
| Segment revenue | Media and Platform Business ¥254,820 thousand (YoY -11.6%), Healthcare Institution Management Support Business ¥1,152,243 thousand (YoY +21.6%), Medical B2B Business ¥33,184 thousand (YoY -9.1%), Cloud Integration Business ¥123,208 thousand (YoY +58.4%), Other regions ¥45 thousand (YoY -94.8%) |
| Segment profit | Media and Platform Business ¥126,281 thousand (YoY -20.2%), Healthcare Institution Management Support Business ¥12,538 thousand (YoY -31.1%), Medical B2B Business ¥-650 thousand, Cloud Integration Business ¥25,508 thousand (YoY +581.2%), Other regions ¥45 thousand (YoY -94.8%) |
| Depreciation and amortization | ¥7,489 thousand |
| Impairment loss | None recognized in the current first quarter |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on Disposal of Fixed Assets ¥1,434 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 1社（株式会社ミルテル） |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 10,773,000 shares |
| Treasury Shares at Period-End | 1,502,530株 |
| Factors Behind Changes in Business Performance | 既存事業のさらなる効率化、歯科業界でのプラットフォーム構築や新サービス開発に取り組み、事業を拡大したこと。HP制作・メンテナンス、歯科医院運営、歯科商社、クラウドインテグレーションでは受注やサービス販売が増加した。 |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.既存事業の効率化を進めながら、歯科業界でのプラットフォーム構築やサービス開発に取り組み、事業を拡大したため。個別には、HP制作・メンテナンス、歯科医院運営、歯科商社、クラウドインテグレーションなどで売上が増加した一方、メディア・プラットフォーム事業では既存メディアへの広告出稿低調や投資先行があった。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.